Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats

Junlan Zhang, Yiqun Ling, Liping Tang, Bao Luo, David M. Pollock, Michael B. Fallon

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Experimental hepatopulmonary syndrome (HPS) after common bile duct ligation (CBDL) in rat is accompanied by increased lung vascular endothelial endothelin B (ETB) receptor expression and increased circulating levels of endothelin-1 (ET-1). The onset of HPS is hypothesized to be triggered by ET-1/ETB receptor activation of endothelial nitric oxide synthase (eNOS)-derived NO production in the pulmonary endothelium. However, whether functional pulmonary vascular ETB receptors are required for the development of experimental HPS is not defined. We evaluated the effects of vascular ETB receptor deficiency on the development of experimental HPS. The molecular and physiological alterations of HPS were compared in 2-wk CBDL wild-type and ETB receptor-deficient (transgenic sl/sl) rats. Relative to wild-type rats, basal hepatic and plasma ET-1 levels were elevated in sl/sl controls although, unlike wild-type animals circulating ET-1 levels, did not increase further after CBDL in sl/sl animals. In contrast to wild-type animals, ETB receptor-deficient rats did not develop increased Akt and eNOS expression and activation and did not develop gas exchange abnormalities of HPS after CBDL. There was a similar degree of pulmonary intravascular monocyte accumulation in both 2-wk CBDL sl/sl and wild-type animals. In conclusion, ETB receptor deficiency inhibits lung Akt/eNOS activation and prevents the onset of experimental HPS after CBDL. This effect is independent of inhibition of pulmonary intravascular monocyte accumulation. These results demonstrate that ET-1/ETB receptor signaling plays a key role in the initiation of experimental HPS.

Original languageEnglish (US)
Pages (from-to)G704-G708
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume296
Issue number4
DOIs
StatePublished - Apr 1 2009
Externally publishedYes

Fingerprint

Hepatopulmonary Syndrome
Endothelin B Receptors
Common Bile Duct
Endothelin-1
Ligation
Lung
Wild Animals
Nitric Oxide Synthase Type III
Blood Vessels
Monocytes
Endothelium
Gases

Keywords

  • Common bile duct ligation
  • Endothelial nitric oxide synthase
  • Endothelin-1
  • Intravascular monocyte

ASJC Scopus subject areas

  • Physiology
  • Hepatology
  • Gastroenterology
  • Physiology (medical)

Cite this

Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats. / Zhang, Junlan; Ling, Yiqun; Tang, Liping; Luo, Bao; Pollock, David M.; Fallon, Michael B.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 296, No. 4, 01.04.2009, p. G704-G708.

Research output: Contribution to journalArticle

Zhang, Junlan ; Ling, Yiqun ; Tang, Liping ; Luo, Bao ; Pollock, David M. ; Fallon, Michael B. / Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2009 ; Vol. 296, No. 4. pp. G704-G708.
@article{05c140426c7f417a823c4d06581664bc,
title = "Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats",
abstract = "Experimental hepatopulmonary syndrome (HPS) after common bile duct ligation (CBDL) in rat is accompanied by increased lung vascular endothelial endothelin B (ETB) receptor expression and increased circulating levels of endothelin-1 (ET-1). The onset of HPS is hypothesized to be triggered by ET-1/ETB receptor activation of endothelial nitric oxide synthase (eNOS)-derived NO production in the pulmonary endothelium. However, whether functional pulmonary vascular ETB receptors are required for the development of experimental HPS is not defined. We evaluated the effects of vascular ETB receptor deficiency on the development of experimental HPS. The molecular and physiological alterations of HPS were compared in 2-wk CBDL wild-type and ETB receptor-deficient (transgenic sl/sl) rats. Relative to wild-type rats, basal hepatic and plasma ET-1 levels were elevated in sl/sl controls although, unlike wild-type animals circulating ET-1 levels, did not increase further after CBDL in sl/sl animals. In contrast to wild-type animals, ETB receptor-deficient rats did not develop increased Akt and eNOS expression and activation and did not develop gas exchange abnormalities of HPS after CBDL. There was a similar degree of pulmonary intravascular monocyte accumulation in both 2-wk CBDL sl/sl and wild-type animals. In conclusion, ETB receptor deficiency inhibits lung Akt/eNOS activation and prevents the onset of experimental HPS after CBDL. This effect is independent of inhibition of pulmonary intravascular monocyte accumulation. These results demonstrate that ET-1/ETB receptor signaling plays a key role in the initiation of experimental HPS.",
keywords = "Common bile duct ligation, Endothelial nitric oxide synthase, Endothelin-1, Intravascular monocyte",
author = "Junlan Zhang and Yiqun Ling and Liping Tang and Bao Luo and Pollock, {David M.} and Fallon, {Michael B.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1152/ajpgi.90627.2008",
language = "English (US)",
volume = "296",
pages = "G704--G708",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats

AU - Zhang, Junlan

AU - Ling, Yiqun

AU - Tang, Liping

AU - Luo, Bao

AU - Pollock, David M.

AU - Fallon, Michael B.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Experimental hepatopulmonary syndrome (HPS) after common bile duct ligation (CBDL) in rat is accompanied by increased lung vascular endothelial endothelin B (ETB) receptor expression and increased circulating levels of endothelin-1 (ET-1). The onset of HPS is hypothesized to be triggered by ET-1/ETB receptor activation of endothelial nitric oxide synthase (eNOS)-derived NO production in the pulmonary endothelium. However, whether functional pulmonary vascular ETB receptors are required for the development of experimental HPS is not defined. We evaluated the effects of vascular ETB receptor deficiency on the development of experimental HPS. The molecular and physiological alterations of HPS were compared in 2-wk CBDL wild-type and ETB receptor-deficient (transgenic sl/sl) rats. Relative to wild-type rats, basal hepatic and plasma ET-1 levels were elevated in sl/sl controls although, unlike wild-type animals circulating ET-1 levels, did not increase further after CBDL in sl/sl animals. In contrast to wild-type animals, ETB receptor-deficient rats did not develop increased Akt and eNOS expression and activation and did not develop gas exchange abnormalities of HPS after CBDL. There was a similar degree of pulmonary intravascular monocyte accumulation in both 2-wk CBDL sl/sl and wild-type animals. In conclusion, ETB receptor deficiency inhibits lung Akt/eNOS activation and prevents the onset of experimental HPS after CBDL. This effect is independent of inhibition of pulmonary intravascular monocyte accumulation. These results demonstrate that ET-1/ETB receptor signaling plays a key role in the initiation of experimental HPS.

AB - Experimental hepatopulmonary syndrome (HPS) after common bile duct ligation (CBDL) in rat is accompanied by increased lung vascular endothelial endothelin B (ETB) receptor expression and increased circulating levels of endothelin-1 (ET-1). The onset of HPS is hypothesized to be triggered by ET-1/ETB receptor activation of endothelial nitric oxide synthase (eNOS)-derived NO production in the pulmonary endothelium. However, whether functional pulmonary vascular ETB receptors are required for the development of experimental HPS is not defined. We evaluated the effects of vascular ETB receptor deficiency on the development of experimental HPS. The molecular and physiological alterations of HPS were compared in 2-wk CBDL wild-type and ETB receptor-deficient (transgenic sl/sl) rats. Relative to wild-type rats, basal hepatic and plasma ET-1 levels were elevated in sl/sl controls although, unlike wild-type animals circulating ET-1 levels, did not increase further after CBDL in sl/sl animals. In contrast to wild-type animals, ETB receptor-deficient rats did not develop increased Akt and eNOS expression and activation and did not develop gas exchange abnormalities of HPS after CBDL. There was a similar degree of pulmonary intravascular monocyte accumulation in both 2-wk CBDL sl/sl and wild-type animals. In conclusion, ETB receptor deficiency inhibits lung Akt/eNOS activation and prevents the onset of experimental HPS after CBDL. This effect is independent of inhibition of pulmonary intravascular monocyte accumulation. These results demonstrate that ET-1/ETB receptor signaling plays a key role in the initiation of experimental HPS.

KW - Common bile duct ligation

KW - Endothelial nitric oxide synthase

KW - Endothelin-1

KW - Intravascular monocyte

UR - http://www.scopus.com/inward/record.url?scp=67149118985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67149118985&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.90627.2008

DO - 10.1152/ajpgi.90627.2008

M3 - Article

C2 - 19196949

AN - SCOPUS:67149118985

VL - 296

SP - G704-G708

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 4

ER -